Restoration of speech in severe aphasia by intravenous and oral priscol.
D061605:Administration, Intravenous; D001037:Aphasia / Q000628:therapy*; D006801:Humans; D013060:Speech; D013565:Sympatholytics / Q000627:therapeutic use*; D014043:Tolazoline
D013565:Sympatholytics; D014043:Tolazoline
APHASIA/therapy; SYMPATHOLYTICS/therapeutic use